BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2657346)

  • 1. Chemotherapy of streptococcal infections: implications of antimicrobial drug resistance in Streptococcus pyogenes.
    Hansman D
    Med J Aust; 1989 Jun; 150(11):611-2. PubMed ID: 2657346
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic implications of erythromycin resistance in group A streptococci.
    Coonan K; Kaplan EL
    Pediatr Infect Dis J; 1993 Mar; 12(3):261-2. PubMed ID: 8451111
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona].
    Viñado B; Domínguez J; Rodrigo C; Matas L
    Med Clin (Barc); 1999 Apr; 112(14):556. PubMed ID: 10363246
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resistance to macrolides in Streptococcus pyogenes].
    Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
    [No Abstract]   [Full Text] [Related]  

  • 5. Leg ulcer infection with an erythromycin-resistant Streptococcus pyogenes.
    Hardie R; Hardie RA
    Scott Med J; 1986 Jan; 31(1):39. PubMed ID: 3515552
    [No Abstract]   [Full Text] [Related]  

  • 6. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
    Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
    Cornaglia G; Ligozzi M; Mazzariol A; Valentini M; Orefici G; Fontana R
    Emerg Infect Dis; 1996; 2(4):339-42. PubMed ID: 9011381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin resistance of Streptococcus pyogenes in Madrid.
    Orden B; Perez-Trallero E; Montes M; Martínez R
    Pediatr Infect Dis J; 1998 Jun; 17(6):470-3. PubMed ID: 9655536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin resistance in Finland declines after reduction in macrolide use.
    Am J Health Syst Pharm; 1997 Nov; 54(21):2436-7. PubMed ID: 9359947
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythromycin resistance in Streptococcus pyogenes in Italy.
    Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
    Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus pyogenes: resistant, tolerant, neither or both?
    Mortensen JE; McDowell T
    Adv Exp Med Biol; 1995; 390():109-17. PubMed ID: 8718606
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrolide-resistant group a streptococcus--now in the United States.
    Huovinen P
    N Engl J Med; 2002 Apr; 346(16):1243-5. PubMed ID: 11961156
    [No Abstract]   [Full Text] [Related]  

  • 13. Infections with beta-Hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin.
    Dixon JM; Lipinski AE
    J Infect Dis; 1974 Oct; 130(4):351-6. PubMed ID: 4613758
    [No Abstract]   [Full Text] [Related]  

  • 14. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.
    Sanders E; Foster MT; Scott D
    N Engl J Med; 1968 Mar; 278(10):538-40. PubMed ID: 4966066
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in Streptococcus pyogenes resistance to erythromycin in Slovakia: is there a correlation with consumption?
    Krcmery V; Foltan V; Langsadl L; Liskov A; Babela R
    Scand J Infect Dis; 2002; 34(5):400. PubMed ID: 12069033
    [No Abstract]   [Full Text] [Related]  

  • 16. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and characteristics of Streptococcus pyogenes resistant to lincomycin and erythromycin.
    Dixon JM; Lipinski AE
    J Med Microbiol; 1973 May; 6(2):Pxv. PubMed ID: 4575282
    [No Abstract]   [Full Text] [Related]  

  • 18. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia.
    Stingemore N; Francis GR; Toohey M; McGechie DB
    Med J Aust; 1989 Jun; 150(11):626-7, 630-1. PubMed ID: 2657347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin-resistant Streptococcus pyogenes in Argentina.
    Lopardo HA; Hernandez C; Vidal P; Vazquez M; Rosaenz L; Rubinstein G; Smayevsky J; Tokumoto M; Fernandez Lausi A; Daher O; Kaufman S; Soriano SV; Brasili S; Bottiglieri M; Carranza MC
    Medicina (B Aires); 2004; 64(2):143-5. PubMed ID: 15628302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin resistance phenotypes in Swedish clinical isolates of group A streptococci.
    Jasir A; Schalén C
    Adv Exp Med Biol; 1997; 418():443-5. PubMed ID: 9331689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.